Simultaneous RZV and aIIV4 Vaccination

    Not Recruiting
  • End date
    Apr 12, 2023
  • participants needed
  • sponsor
    Duke University
Updated on 13 June 2022


The overall aim of the study is to compare the safety of simultaneous RZV (SHINGRIX) and inactivated adjuvanted influenza vaccine aIIV4 (FLUAD) versus simultaneous RZV (SHINGRIX) and inactivated influenza HD-IIV4 (Fluzone HD) vaccine in persons 65 years. A prospective, randomized, blinded clinical trial that will be conducted during the 2021/2022 and 2022/2023 influenza seasons. Over the course of these two influenza seasons, approximately 220 older adults will be enrolled at Duke University Medical Center, and 180 older adults at Johns Hopkins University Medical Center. Eligible subjects will be randomized to receive either simultaneous RZV/aIIV4 or RZV/HD-IIV4 vaccines. All subjects will be assessed for 7 days post-injection and safety and tolerability compared between the two groups. Serious adverse events and adverse events of clinical interest will be assessed 42 days post-vaccination and compared between the two groups. Health-related quality of life will be assessed pre-vaccination Day 1 through Day 8.


Intention-to-Treat (ITT) Population: Defined as all subjects who are randomized and vaccinated.

Modified Intention-to-Treat (mITT) Population: Defined as all subjects who are randomized, vaccinated, and provide at least one day of complete data on the symptom diary.

Condition adverse drug events, Acute Pain Service, drug reaction, ache, quality-of-life, overdose of drug with toxic effect, Injection Site Reaction, Pain (Pediatric), adverse drug reaction, adverse drug reactions, Post-Surgical Pain, Pain, Quality of life, injection site reactions
Treatment Shingrix®, FLUAD® Quadrivalent, Fluzone® HD Quadrivalent
Clinical Study IdentifierNCT05007041
SponsorDuke University
Last Modified on13 June 2022

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note